Is Telo Genomics Corp halal to invest in?

According to Musaffa's Shariah screening methodology, Telo Genomics Corp (TELO.V) is currently classified as NOT HALAL as of July 2025. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Telo Genomics Corp a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Telo Genomics Corp using these criteria to determine its compliance status.

Can Muslims buy shares of Telo Genomics Corp?

Muslim investors may consider investing in Telo Genomics Corp if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Telo Genomics Corp classified as NOT HALAL?

Musaffa determines the Shariah status of Telo Genomics Corp by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Telo Genomics Corp updated?

The Shariah compliance status of Telo Genomics Corp may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Telo Genomics Corp become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Telo Genomics Corp?

You can check the latest Shariah compliance status of Telo Genomics Corp on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

TELO.V Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: July 15, 2025

Report Source: 2025 3rd Quarter Report

Telo Genomics Corp. Stock Analysis TELO.V

Canada Health Care Nano Cap Report: Q3, 2025

Telo Genomics Corp. is a molecular diagnostics company, which engages in the development of telomere analysis platforms in the industry. The company is headquartered in Toronto, Ontario. The company went IPO on 2012-02-15. Its technologies utilize a multi-step process that involves capturing sample cells from blood or tissue, labeling, 3D formatting, processing and analyzing with TeloView. Its technologies are based on single cell biology. TeloView is a software platform, which is used to quantify specific features of each patient’s telomeres. The company quantifies six specific biological and structural features of telomeres and builds a score for each patient to assess their risk of disease progression and potential treatment response. TeloView helps in capturing the heterogeneity and complexity of cancers with relatively small sample sizes in clinical studies. Its initial lead includes multiple myeloma, prostate cancer and Alzheimer's disease.

Key Statistics of Telo Genomics Corp (TELO.V)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

CAD0.06CAD0.06

Today's Open

CAD0.06

Volume

78.00K

P/E Ratio (TTM)

52 Week Range

CAD0.04CAD0.13

Market Cap

5.02M

Avg. Volume

54.22K

Dividend Yield

Financial Metrics & Statements of Telo Genomics Corp (TELO.V)

FAQ's for Telo Genomics Corp (TELO.V)

According to Musaffa’s Shariah screening methodology, Telo Genomics Corp (TELO.V) is currently classified as NOT HALAL as of July 2025. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.